Intercalating Nucleic Acid Blockers for Methylation Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting methylation changes in DNA, such as those in the GSTP1 gene promoter, rely heavily on PCR amplification after bisulphite modification, which can lead to false positives and are limited by the need for significant DNA amounts and are not sensitive enough to detect low levels of methylation, especially in mixed populations of cells.
Innovation Solution
The use of intercalating nucleic acids (INAs) with internal intercalating pseudonucleotides (IPNs) as blockers in PCR amplification reactions, which specifically block or reduce the amplification of unmethylated sequences, allowing for the sensitive and specific detection of methylated DNA by differentially amplifying methylation status.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If PCR amplification is used to detect methylation changes, then amplification sensitivity is improved, but false positives increase and specificity deteriorates
Solution Approach 1:
The patent introduces an intermediary substance - the amplification blocker - that mediates between the PCR amplification process and the target methylated DNA. This blocker selectively binds to unmethylated sequences, preventing their amplification, while allowing methylated sequences to be amplified. This intermediary mechanism resolves the contradiction by adding a selective filtering step that maintains sensitivity while reducing false positives.
Solution Approach 2:
The amplification blocker exhibits local quality differentiation through its selective binding affinity. It has high affinity for unmethylated sequences (which should be blocked) and low affinity for methylated sequences (which should be amplified). This local differentiation in binding quality allows the system to simultaneously achieve high sensitivity for methylated DNA detection while maintaining high specificity by blocking only the unwanted unmethylated sequences.
2Productivity
If conventional PCR amplification is used, then amplification capability is improved, but detection of low-level methylation in mixed populations becomes difficult
Solution Approach 1:
The patent extracts the problematic unmethylated sequences from the mixed population through selective blocking. By introducing the amplification blocker that specifically binds to and prevents amplification of unmethylated sequences, the system effectively removes the noise component from the mixture. This extraction allows the methylated sequences to be detected with high precision even at low levels in mixed cell populations.
Solution Approach 2:
The patent converts the harmful effect of non-specific amplification (which causes false positives and masks low-level signals) into a beneficial selective blocking mechanism. The amplification blocker transforms the previously problematic amplification of all sequences into a selective process where only desired methylated sequences are amplified, while unwanted unmethylated sequences are blocked. This conversion enables sensitive detection of low-level methylation by eliminating the background noise.
3Measurement precision
If bisulphite modification followed by PCR is used, then methylation status can be determined, but significant DNA amounts are required and the method becomes complex
Solution Approach 1:
The patent merges the methylation detection function with the amplification blocking function into a single integrated assay step. Instead of performing bisulphite modification, separate PCR amplification, and then analysis, the system combines these functions by using the amplification blocker to simultaneously achieve selective amplification of methylated sequences. This merging reduces the number of separate steps and simplifies the overall assay while maintaining accuracy.
4Productivity
If standard amplification blockers are used, then amplification is blocked, but sensitivity and specificity for methylation detection are insufficient
Solution Approach 1:
The patent changes the critical parameter of binding affinity by designing amplification blockers with optimized sequences and structural characteristics. The blockers are designed with specific nucleotide compositions and lengths that give them high affinity for unmethylated sequences while maintaining low affinity for methylated sequences. This parameter optimization enables the system to achieve both strong amplification blocking capability and high detection sensitivity simultaneously.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces false positives, enhances sensitivity, and allows for the detection of low-level methylation in mixed cell populations by selectively amplifying methylated sequences while suppressing unmethylated ones, improving the signal-to-noise ratio in methylation status determination.
Implementation Method 1
intercalating nucleic acids (INAs) with internal intercalating pseudonucleotides (IPNs) as blockers in PCR amplification reactions
Data Source
AI summary
An amplification blocker comprising an intercalating nucleic acid (INA) containing two or more internal intercalating pseudonucleotides (IPNs) capable of blocking or reducing nucleic acid amplification. Use of the amplification blocker to block or reduce nucleic acid amplification.